
For patients with hepatitis C seeking modern treatment options, many health plans force health care professionals use criteria that are clinically unsound.

For patients with hepatitis C seeking modern treatment options, many health plans force health care professionals use criteria that are clinically unsound.

More than just biological factors can affect patient outcomes.

Top stories of the week on Specialty Pharmacy Times.

Self-testing may help control global spread of HIV/AIDS.

Mild psoriasis, severe psoriasis, and psoriatic arthritis may also bring increased comorbidities.

Expansion covers patients who have greater than 30% myeloblasts.

Average time for withdrawals in colonoscopies came in at approximately 8.6 minutes.

Intralesional interleukin-2 shows promise in cutaneous melanoma metastases.

Childhood pneumonia carries a higher risk of chronic bronchitis and other disease-related quality of life issues.

The FDA today approved insulin degludec injection (Tresiba) and insulin degludec/insulin aspart injection (Ryzodeg) to improve glucose control in adults with diabetes.

Veterans who obtain their prescriptions at a VA pharmacy will see their copays remain steady through 2016.

Technology may help improve patient outcomes through enhanced personalized medicine.

National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses changes ahead for specialty pharmacy patients.

Nanopore technology may soon be adapted for early disease detection.

Investigators question if hepatitis A virus originated in animals.

Researchers examine how immunodeficiency diseases avoid immune system attacks.

Sleep disturbances accounted for a quarter of the variance in fatigue among patients with MS.

Current HIV treatment guidelines are based on data obtained primarily from men.

Findings could eliminate need for weeks of treatments that carry severe side effects.

Hepatitis C incidence rate among HIV-positive men who have sex with men grew three-fold from 1991 to 2010.

Research may help tailor treatments to individual patients.

Usability testing should include at least 15 representative end-user participants.

Kyprolis is for injection in patients with relapsed multiple myeloma.

Amid public uproar over its steep price increase for pyrimethamine (Daraprim), Turing Pharma announced last night that it would lower the drug's cost.

Confusion over the drug strength displayed for the new antibacterial agent Avycaz could cause medication errors, the FDA is warning pharmacists.

Patients treated with the drug showed improvements in overall survival.

Michael Zeglinski, Vice President of Specialty Pharmacy Operations at BriovaRx, discusses how health care reform has changed specialty pharmacy.

Each additional year of smoking after multiple sclerosis diagnosis accelerated the time to secondary progressive disease conversion.

Gary Cohen was the sole occupant of a Cessna amphibious plane that crashed in Florida on September 18.

Guidelines help identify and manage potential physical and psychosocial effects of colorectal cancer.